RxDoctor Payments Data

Jacqueline Surrency

Physician Assistant · San Diego, CANPI 1568693398

Payments from drug & device makers

$4,299in general payments, 2019–2025

Across 237 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$745
  • AstraZeneca$671
  • Boehringer Ingelheim$323
  • Teva Pharmaceuticals USA, Inc.$236
  • Xeris Pharmaceuticals, Inc.$162
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$4,299100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,299 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide128$127,154
JardianceEmpagliflozin93$120,607
TrulicityDulaglutide29$34,336
Diclofenac Sodium25$29,143
XareltoRivaroxaban27$24,102
FarxigaDapagliflozin Propanediol28$21,714
Synjardy XrEmpagliflozin/Metformin Hcl12$18,283
MounjaroTirzepatide15$14,498
Xigduo XrDapaglifloz Propaned/Metformin20$14,121
RybelsusSemaglutide12$12,370
Tresiba Flextouch U-200Insulin Degludec18$9,845
Soliqua 100-33Insulin Glargine/Lixisenatide17$8,681
Spiriva RespimatTiotropium Bromide13$6,569
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog14$5,847
Atorvastatin Calcium300$4,344

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr, Spiriva Respimat$323$145,459118 claims
Novo NordiskOzempic, Rybelsus$1,116$139,525140 claims
Lilly USA, LLCTrulicity, Mounjaro$745$48,83344 claims
AstraZenecaFarxiga$671$21,71428 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$119$8,68117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.

Other physician assistant in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →